Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2023

Jun 20, 2023

33899_dirs_2023-06-20_e0cc59eb-4e00-4147-92e5-2ec847ac5343.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-06-15

Reporting Person: BROWN JEFFREY J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-06-15 Common Stock A 3289 Acquired 5681.154 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 37694.873 Indirect
Common Stock 4069.112 Indirect

Footnotes

F1: Represents the right to receive 3,289 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024.

F2: These shares are directly owned by Brown Equity Partners, LLC, for which the reporting persons is the managing member.

F3: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.